Biochemistry, Cancer Biology, Neuroscience, Pharmacology
School of Medicine
(615) 327-6796 | email@example.com
1. Differentiating ulcerative colitis and Crohn’s colitis through proteomic patterns, NIH/NIDDK
2. Role of free hemoglobin alpha chain in colitis-associated colorectal cancer, VICC GI SPORE
3. Targeted DEFA5 Abs and assay methods for diagnosing and treating inflammatory bowel disease, VICTR
Adenocarcinoma at the Ileostomy Site After a Proctocolectomy for Ulcerative Colitis and/or Familial Adenomatous Polyposis: An Overview.
Samuel D James, Alexander T Hawkins, Amosy E M'Koma
Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis.
Alexander T Hawkins, Jun W Um, Amosy E M'Koma
Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
Amanda D Williams, Olga Y Korolkova, Amos M Sakwe, Timothy M Geiger, Samuel D James, Roberta L Muldoon, Alan J Herline, J Shawn Goodwin, Michael G Izban, Mary K Washington, Duane T Smoot, Billy R Ballard, Maria Gazouli, Amosy E M'Koma
Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis.
Billy Ray Ballard, Amosy Ephreim M'Koma
Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.
Olga Y Korolkova, Jeremy N Myers, Samuel T Pellom, Li Wang, Amosy E M'Koma
Serum protein profiling of adults and children with Crohn disease.
Anna Vaiopoulou, Maria Gazouli, Aggeliki Papadopoulou, Athanassios K Anagnostopoulos, George Karamanolis, George E Theodoropoulos, Amosy M'Koma, George T Tsangaris
Surgery, Inflammatory bowel disease, Biomarker, Colitis-associated colorectal cancer, Molecular diagnostics